HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gregory J del Zoppo Selected Research

Gregory J del Zoppo Research Topics

Disease

13Stroke (Strokes)
11/2014 - 01/2004
9Brain Ischemia (Cerebral Ischemia)
04/2014 - 12/2003
5Ischemia
09/2012 - 02/2005
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2014 - 12/2003
3Hemorrhage
01/2014 - 12/2009
3Inflammation
09/2012 - 01/2004
2Brain Edema (Cerebral Edema)
04/2014 - 09/2007
2Edema
04/2014 - 05/2012
2Anoxia (Hypoxia)
08/2010 - 05/2008
2Brain Hypoxia (Cerebral Hypoxia)
08/2010 - 05/2008
2Multiple Sclerosis
06/2007 - 09/2006
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2007 - 09/2006
1Wounds and Injuries (Trauma)
11/2013
1Cerebral Hemorrhage
05/2012
1Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2009
1Aneurysm (Aneurysms)
12/2008
1Transient Ischemic Attack
09/2007
1Demyelinating Diseases (Demyelinating Disease)
06/2007
1Central Nervous System Diseases (CNS Diseases)
02/2007
1Neoplasms (Cancer)
09/2006
1Arteriovenous Malformations (Arteriovenous Malformation)
09/2006
1Brain Injuries (Brain Injury)
09/2006
1Infection
06/2003

Drug/Important Bio-Agent (IBA)

4Tissue Plasminogen Activator (Alteplase)FDA Link
11/2014 - 12/2003
4Fibronectins (Fibronectin)IBA
05/2012 - 06/2007
2sulfonylurea receptorIBA
04/2014 - 09/2007
2Glyburide (Glibenclamide)FDA LinkGeneric
04/2014 - 09/2007
2Plasminogen Activators (Plasminogen Activator)IBA
06/2013 - 10/2010
2AntigensIBA
05/2012 - 12/2003
2OxygenIBA
05/2012 - 04/2008
2VitronectinIBA
05/2012 - 06/2007
2Glucose (Dextrose)FDA LinkGeneric
05/2012 - 04/2008
2Peptide Hydrolases (Proteases)IBA
10/2010 - 04/2004
2Ancrod (Arvin)IBA
12/2009 - 05/2009
2Proteins (Proteins, Gene)IBA
04/2008 - 02/2007
2Interleukin-6 (Interleukin 6)IBA
01/2004 - 06/2003
14- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
11/2014
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2014
1Blood Coagulation Factors (Coagulation Factor)IBA
11/2013
1Amyloid (Amyloid Fibrils)IBA
09/2012
1Fibrinogen (Factor I)FDA Link
05/2009
1Integrin alpha5beta1IBA
05/2008
1perlecanIBA
04/2008
1CollagenIBA
04/2008
1Dystroglycans (Dystroglycan)IBA
04/2008
1Laminin (Merosin)IBA
04/2008
1IntegrinsIBA
01/2008
1tebufenozide (Mimic)IBA
01/2008
1Blood Glucose (Blood Sugar)IBA
09/2007
1Adenosine Triphosphate (ATP)IBA
09/2007
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2007
1Blood Proteins (Serum Proteins)IBA
06/2007
1adhesion receptorIBA
09/2006
1LigandsIBA
09/2006
1Neurotransmitter Agents (Neurotransmitter)IBA
02/2005
1Messenger RNA (mRNA)IBA
12/2003
1Matrix Metalloproteinase 16IBA
12/2003
1Matrix MetalloproteinasesIBA
12/2003
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2003
1progelatinaseIBA
12/2003
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2003
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2003
1Plasminogen Activator Inhibitor 1IBA
12/2003

Therapy/Procedure

1Aftercare (After-Treatment)
11/2014
1Stents
01/2014
1Thrombolytic Therapy
01/2014
1Endovascular Procedures
01/2014
1Intravenous Infusions
05/2009
1Surgical Instruments (Clip)
12/2008
1Therapeutics
12/2008